Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder

Otsuka

Status and phase: Completed; Phase 3

Conditions: Bipolar Disorder

Treatments: Drug: aripiprazole

Study type: Interventional

Funder types: Industry

Identifiers

NCT00036101

CN138-074

Details and patient eligibility

About

The purpose of this study is to learn if aripiprazole is effective for the treatment of patients with acute symptoms of Bipolar disorder.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Patients with acute symptoms of Bipolar Disorder